Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veradigm Inc (MDRX)

Veradigm Inc (MDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 522,720
  • Shares Outstanding, K 108,900
  • Annual Sales, $ 588,020 K
  • Annual Income, $ -86,460 K
  • EBIT $ 36 M
  • EBITDA $ 152 M
  • 60-Month Beta 0.52
  • Price/Sales 0.59
  • Price/Cash Flow 5.53
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.20
  • Most Recent Earnings N/A on 11/07/22
  • Next Earnings Date 09/30/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 5.230 on 10/13/08
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.1500 +19.28%
on 12/08/25
5.6000 -11.61%
on 11/28/25
+0.1500 (+3.12%)
since 11/07/25
3-Month
3.5000 +41.43%
on 10/21/25
6.0000 -17.50%
on 11/04/25
+0.1000 (+2.06%)
since 09/08/25
52-Week
3.0000 +65.00%
on 08/25/25
11.0000 -55.00%
on 12/09/24
-6.0000 (-54.79%)
since 12/06/24

Most Recent Stories

More News
Veradigm Launches Enhanced Ambient Scribe Capabilities

AI-powered solution includes multilingual support, structured diagnosis code recommendations, and clinical decision insights support tools for Veradigm EHR customers

MDRX : 4.9500 (+3.13%)
Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

Major Mid-Atlantic and Southeast US Health Plan to Deploy Integrated Care Gap Alerting in Early 2026

MDRX : 4.9500 (+3.13%)
Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

Healthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint

MDRX : 4.9500 (+3.13%)
Veradigm Provides 2025 Business Update

Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing estimated financial performance for the second quarter of 2025...

MDRX : 4.9500 (+3.13%)
Veradigm to Release Business Update September 30th and Host Investor Call October 1st

Veradigm ® (OTCEM: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the...

MDRX : 4.9500 (+3.13%)
Veradigm Amends and Extends Stockholder Rights Plan

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s...

MDRX : 4.9500 (+3.13%)
Veradigm Appoints Don Trigg as Chief Executive Officer

Former apree health CEO, Cerner President will Lead Next Phase of Company Growth

MDRX : 4.9500 (+3.13%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc. - MDRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are...

MDRX : 4.9500 (+3.13%)
MDRX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Veradigm Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Veradigm Inc. (NASDAQ: MDRX)...

MDRX : 4.9500 (+3.13%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc.- MDRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are...

MDRX : 4.9500 (+3.13%)

Business Summary

Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 4.9500
2nd Resistance Point 4.9000
1st Resistance Point 4.8500
Last Price 4.9500
1st Support Level 4.7500
2nd Support Level 4.7000
3rd Support Level 4.6500

See More

52-Week High 11.0000
Fibonacci 61.8% 7.9440
Fibonacci 50% 7.0000
Fibonacci 38.2% 6.0560
Last Price 4.9500
52-Week Low 3.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar